Pilots complete hundreds of hours of flight ✈️ simulation before carrying hundreds of passengers. Why shouldn’t we apply the same philosophy before enrolling hundreds of patients into clinical trials 💊 💉 ?
Excited to share our work on an AI-powered framework, led by #CodetoClinic team @ZuhairMajeed@PengLi_AI@docnurlan that emulates a Phase III trial in #RCC through ML model transfer.
Great discussions with @realrickpazdur@US_FDA and @AACR #AACRdrugdev26 Program Chair @lillian_siu on the future of in silico clinical trials, real-world evidence, and AI-driven drug development.
I believe in silico trials will become a routine step in clinical development, improving trial design before the first patient is enrolled.
#InSilicoTrials #AI #ClinicalTrials #KidneyCancer
@OSUCCC_James@OhioStatePIIO@Pelotonia@OSUWexMed@OhioStateMedOnc@KidneyCancer
The conference was also an invaluable opportunity to engage with our #buckeye family, colleagues and esteemed leaders in the field of oncology. Looking forward to returning to the lab & continuing our code to clinic mission! 🧬💻
@ASCO@OSUCCC_James@OhioStatePIIO@Pelotonia
Excited to share our upcoming presentations at #ASCO2026 from the @HasanovLab@OhioStatePIIO and collaborators.
This year, our team will present 12 studies spanning:
https://t.co/jlGQZKe0vq
🤖 AI/ML precision oncology
🧠 RCC brain metastasis biology
🧫 Spatial & single-cell transcriptomics
🌎 Real-world outcomes research with ML models
💻 In silico clinical trial modeling
These projects reflect our 💻 #CodetoClinic 👩⚕️👨⚕️translational framework, integrating computational oncology, multi-omics, and clinical research to advance precision cancer care.
Grateful to our incredible trainees, collaborators, patients, and mentors who made this work possible. https://t.co/8SlON6F4d0
@OSUCCC_James@ASCOPost@ASCO@KidneyCancer@kidneycan@urotoday@OncoAlert@oncodaily@OncLive
#KidneyCancer #BrainMetastases #PrecisionOncology #AIinOncology #SpatialBiology #SingleCell #TranslationalResearch